Filter By Industry
Filter By Tag


Neuronity Therapeutics, Inc. Press releases

1 - 1 of 1 Press Release

Jul 03, 2023
Neuronity Therapeutics, Inc., a pioneering biotech company focused on neurodegenerative diseases, is delighted to announce the receipt of a $780k grant in collaboration with the University of Georgia (UGA) from The Michael J. Fox Foundation (MJFF).

Neuronity Therapeutics, Inc. RSS Feed